IMMUTEP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.42 AUD | -6.67% |
|
+18.31% | +21.74% |
| 04-24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
| 04-24 | Immutep Limited Announces Positive Preliminary Topline Results from TACTI-003 Cohort B | CI |
Chart calendar Immutep Limited
a3d978c94227eb360c300a2d895ac2e.3oxBSehCQp3j1U1SlR6ovEpDVa30YG5Tdje-wcot9Y0.n8dsOJgABMW3hjs15H-d8gJyJ_-5USs9Q1Hcg75Fo--04xkFjBoUzLObLg~049be60f19b53730b6c56d9def805233
Upcoming events on Immutep Limited
Past events on Immutep Limited
| 27/02/2024 22:39 | Q2 2024 Earnings Release |
| 16/02/2024 01:30 | ShareCafe Hidden Gems Webinar |
| 06/02/2024 04:40 | Euroz Hartleys Healthcare Forum |
| 29/01/2024 21:32 | December 2023 Sales and Revenue Release - Activities Report |
| 07/01/2024 | JPMorgan Healthcare Conference |
| 15/11/2023 15:00 | Jefferies London Healthcare Conference |
| 13/11/2023 | Immuno-Oncology Europe Conference |
| 09/11/2023 15:30 | Baird Biotech Discovery Series |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 595 |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number : 595 |
| 31/10/2023 | AusBiotech Conference |
| 31/10/2023 12:00 | September 2023 Sales and Revenue Release - Activities Report |
| 24/10/2023 | Wilsons Drug and Device Healthcare Conference |
| 24/10/2023 00:30 | Annual General Meeting |
| 22/10/2023 | European Society for Medical Oncology Congress - Poster No: 1987TiP |
| 22/10/2023 | European Society for Medical Oncology Congress - Poster No: 1042P |
| 22/10/2023 22:00 | European Society for Medical Oncology Congress |
| 21/10/2023 08:05 | European Society for Medical Oncology Congress - Abstract No: 2174 |
| 26/09/2023 19:45 | Cantor Global Healthcare Conference |
| 13/09/2023 06:50 | E&P Small Caps Conference |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 7,49 0,00 - | 16,5 13,0 26.47% | 0,00 4,95 - | 6,76 4,04 67.13% | 5,20 6,15 -15.41% | 3,19 |
|
EBITDA Million AUD | Released Forecast Spread | -18,3 -7,55 -142.58% | 0,00 0,00 - | -17,6 -19,1 7.93% | -30,1 -35,5 15.3% | -37,8 -41,3 8.49% | -47,0 |
|
EBIT Million AUD | Released Forecast Spread | -20,2 -15,0 -34.9% | -12,3 -15,6 20.94% | -19,7 -24,1 18.34% | -32,1 -36,9 12.9% | -39,9 -44,2 9.86% | -47,4 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -18,3 -18,5 0.96% | -13,5 -15,4 12.69% | -29,9 -30,8 2.83% | -32,2 -36,8 12.45% | -39,9 -43,4 8.08% | -45,9 |
|
Net income Million AUD | Released Forecast Spread | -18,3 -12,8 -43.47% | -13,5 -15,4 12.47% | -29,9 -30,8 2.83% | -32,2 -36,8 12.45% | -39,9 -43,4 8.08% | -45,2 |
|
EPS AUD | Released Forecast Spread | -0,06 -0,03 -90% | -0,03 0,00 -1020% | -0,05 -0,04 -13.93% | -0,04 -0,04 12.63% | -0,04 -0,04 -3% | -0,04 |
| Announcement Date | 20/08/19 | 25/08/20 | 30/08/21 | 31/08/22 | 29/08/23 | - |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 0,00 - | 0,00 1,08 - | 2,08 1,40 48.57% | 3,91 3,20 22.07% | 2,62 3,23 -19.05% | 4,11 2,10 95.73% | 0,67 | |||
|
EBITDA Million AUD | Released Forecast Spread | -9,34 -9,40 0.62% | -8,24 -9,70 15% | -15,0 -15,1 0.99% | -15,7 -16,2 3.21% | -19,7 | -21,8 | -23,8 | -26,0 | ||
|
EBIT Million AUD | Released Forecast Spread | -5,37 -5,10 -5.37% | -6,94 -9,52 27.09% | -10,4 -12,3 15.38% | -9,26 -13,5 31.62% | -16,8 -15,1 -11.65% | -15,9 -17,9 11.42% | -20,6 -19,0 -8.69% | -19,3 -22,6 14.77% | -21,2 -23,9 11.13% | -26,2 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -5,95 -5,10 -16.69% | -7,52 -9,57 21.42% | -19,8 -14,1 -41.17% | -10,1 -15,3 34.43% | -16,3 -15,1 -8.1% | -15,9 -18,0 11.44% | -20,6 -19,2 -7.18% | -19,3 -21,2 9.06% | -21,2 -23,7 10.48% | -25,3 |
|
Net income Million AUD | Released Forecast Spread | -5,95 -5,10 -16.7% | -7,52 -9,52 21% | -19,8 -14,1 -41.17% | -10,1 -15,3 34.43% | -16,3 -15,1 -8.1% | -15,9 -18,1 11.69% | -20,6 -12,8 -60.78% | -19,3 -21,9 11.98% | -21,2 -23,7 10.48% | -25,0 |
|
EPS AUD | Released Forecast Spread | -0,04 -0,04 4.25% | -0,01 -0,03 52% | -0,02 -0,02 0% | -0,02 -0,02 15.91% | -0,02 -0,02 -2.61% | -0,02 -0,02 14.76% | -0,02 | |||
| Announcement Date | 20/02/20 | 25/08/20 | 23/02/21 | 30/08/21 | 24/02/23 | 31/08/22 | 24/02/23 | 29/08/23 | 27/02/24 | - |
More events
Past sector events for Immutep Limited
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMM Stock
- Calendar Immutep Limited
